Posts Tagged ‘science geek’

Just a few days ago, I was giving one of my anatomy lectures about the brain. Now and then, I’ll be in the middle of lecture prep, and even when I’m in the middle of a topic I’ve read about a dozen times, a “new discovery” about myself hits me. And, recently, it did. You […]

If you have MS, or know anything about the nervous system, you may be familiar with myelin. Bottom line–myelin is the “insulation” on the nerves, as they send information from our brain and spinal cord out to our muscles. For those of us with MS, the myelin is partially degenerated, due to the immune system […]

mri and ms


Marching forward into a new month! Spring is almost here–hooray! Continuing with my series on education about MS: part of our diagnosis (and continued monitoring) is through magnetic resonance imaging, or MRI. Why, and how? Well, those of us with MS have damage to the myelin sheath–the protective layer around our nerves. This is composed […]

Here’s an article that came out recently: Can Indazole Chloride Cure MS? It’s a lot of sciencey-geeky stuff in the article (of which I am one, so let me sum it up)–but bottom line, this compound seems to mimic the effects of estrogen without most of the nasty side-effects–higher risk of breast and ovarian cancer […]

OK, I’ve drawn much of this conclusion before. But I figured I’d reiterate my thoughts, since I haven’t seen this talked about anywhere, really. People with MS develop chronic pain. Yes, it’s a nervous system disorder. The nervous system is this big, amorphous, not-well-understood thing. And the source of much of this pain is also […]

I’m back teaching nutrition again this quarter (as if you couldn’t tell… from all of my nutrition-related ramblings) and, once again, I told my new group about why it truly is important at the molecular level to consume our nutrients. Well, as a child growing, we know it’s important, because you’re building structures of your […]



It’s been an exciting past few years in the drug development pipeline for MS (among other diseases). As someone who studied pharmaceutical science in graduate school nearly 20 years ago, as I vaguely follow industry news, I (and others) had thought that new pathways of drug discovery had dried up. Or so the media was […]